Abstract
Cystic fibrosis (CF) is the most frequent lethal genetic disorder among Caucasians, but is considered to be a very rare disease in Chinese population. Here, we present an 11-year-old Chinese CF patient with disseminated bronchiectasis and salty sweat, for whom exon sequencing followed by multiplex ligation-dependent probe amplification analysis of the CFTR gene was applied for mutation screening. A homozygous deletion involving exon 20 of CFTR was observed in the patient’s genome. Molecular characterization of the breakpoints indicated that both alleles of this locus had an identical novel complex rearrangement (c.3140-454_c.3367+249del931ins13, p.R1048_G1123del), leading to an in-frame removal of 76 amino acid residues in the second transmembrane domains of the CFTR protein. Although a same haplotype containing this complex rearrangement was observed on both of the maternal and paternal alleles, the parents denied any blood relationship as far as they know. Genome-wide homozygosity mapping was performed through SNP microarray and only a single homozygous interval of ~14.1 Mb at chromosome 7 containing the CFTR gene was observed, indicating the possible origin of the deletion from a common ancestor many generations ago. This study expands the mutation spectrum of CFTR in patients of Chinese origin and further emphasizes the necessity of MLPA analysis in mutation screening for CF patients.
Similar content being viewed by others
Abbreviations
- CF:
-
Cystic fibrosis
- CFTR:
-
Cystic fibrosis transmembrane conductance regulator
- SNV:
-
Single-nucleotide variations
- MLPA:
-
Multiplex ligation-dependent probe amplification
- FEV1:
-
Forced expiratory volume in 1 s
- FVC:
-
Forced vital capacity
- CT:
-
Computed tomography
- qPCR:
-
Quantitative real-time PCR
- MAF:
-
Minor allele frequencies
- TMD:
-
Transmembrane domain
References
Audrezet MP, Chen JM, Raguenes O, Chuzhanova N, Giteau K, Le Marechal C, Quere I, Cooper DN, Ferec C (2004) Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms. Hum Mutat 23:343–357
Cer RZ, Donohue DE, Mudunuri US, Temiz NA, Loss MA, Starner NJ, Halusa GN, Volfovsky N, Yi M, Luke BT, Bacolla A, Collins JR, Stephens RM (2013) Non-B DB v2.0: a database of predicted non-B DNA-forming motifs and its associated tools. Nucleic Acids Res 41:D94–D100
Chuzhanova N, Chen JM, Bacolla A, Patrinos GP, Ferec C, Wells RD, Cooper DN (2009) Gene conversion causing human inherited disease: evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair. Hum Mutat 30:1189–1198
Colombo C, Littlewood J (2011) The implementation of standards of care in Europe: state of the art. J Cyst Fibros 10:S7–S15
Fanen P, Wohlhuter-Haddad A, Hinzpeter A (2014) Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies. Int J Biochem Cell Biol 52:94–102
Ferec C, Casals T, Chuzhanova N, Macek M Jr, Bienvenu T, Holubova A, King C, McDevitt T, Castellani C, Farrell PM, Sheridan M, Pantaleo SJ, Loumi O, Messaoud T, Cuppens H, Torricelli F, Cutting GR, Williamson R, Ramos MJ, Pignatti PF, Raguenes O, Cooper DN, Audrezet MP, Chen JM (2006) Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms. Eur J Hum Genet 14:567–576
Feuillet-Fieux MN, Ferrec M, Gigarel N, Thuillier L, Sermet I, Steffann J, Lenoir G, Bonnefont JP (2004) Novel CFTR mutations in black cystic fibrosis patients. Clin Genet 65:284–287
Guillot L, Beucher J, Tabary O, Le Rouzic P, Clement A, Corvol H (2014) Lung disease modifier genes in cystic fibrosis. Int J Biochem Cell Biol 52:83–93
Hantash FM, Redman JB, Starn K, Anderson B, Buller A, McGinniss MJ, Quan F, Peng M, Sun W, Strom CM (2006) Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screening. Hum Genet 119:126–136
Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073–1080
Liu Y, Wang L, Tian X, Xu K-F, Xu W, Li X, Yue C, Zhang P, Xiao Y, Zhang X (2015) Characterization of gene mutations and phenotypes of cystic fibrosis in Chinese patients. Respirology 20:312–318
Magnani C, Cremonesi L, Giunta A, Magnaghi P, Taramelli R, Ferrari M (1996) Short direct repeats at the breakpoints of a novel large deletion in the CFTR gene suggest a likely slipped mispairing mechanism. Hum Genet 98:102–108
Quemener S, Chen JM, Chuzhanova N, Benech C, Casals T, Macek M Jr, Bienvenu T, McDevitt T, Farrell PM, Loumi O, Messaoud T, Cuppens H, Cutting GR, Stenson PD, Giteau K, Audrezet MP, Cooper DN, Ferec C (2010) Complete ascertainment of intragenic copy number mutations (CNMs) in the CFTR gene and its implications for CNM formation at other autosomal loci. Hum Mutat 31:421–428
Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL et al (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066–1073
Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N et al (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059–1065
Seelow D, Schuelke M, Hildebrandt F, Nurnberg P (2009) HomozygosityMapper—an interactive approach to homozygosity mapping. Nucleic Acids Res 37:W593–W599
Shen Y, Liu J, Zhong L, Mogayzel PJ Jr, Zeitlin PL, Sosnay PR, Zhao S (2016) Clinical phenotypes and genotypic spectrum of cystic fibrosis in chinese children. J Pediatr 171(269–276):e261
Tang S, Moonnumakal SP, Stevens B, Douglas G, Mason S, Schmitt ES, Eng CM, Katz M, Fang P (2013) Characterization of a recurrent 3.8 kb deletion involving exons 17a and 17b within the CFTR gene. J Cyst Fibros 12:290–294
The CF Foundation, Johns Hopkins University, The Hospital for Sick Children (2011) The Clinical and Functional TRanslation of CFTR (CFTR2) Database. http://www.cftr2.org. Accessed 1 Mar 2017
The International HapMap Consortium (2003) The international HapMap project. Nature 426:789–796
Tian X, Liu Y, Yang J, Wang H, Liu T, Xu W, Li X, Zhu Y, Xu KF, Zhang X (2016) p.G970D is the most frequent CFTR mutation in Chinese patients with cystic fibrosis. Hum Genome Var 3:15063
Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, Palomaki GE, Popovich BW, Pratt VM, Rohlfs EM, Strom CM, Richards CS, Witt DR, Grody WW (2004) Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 6:387–391
Wells RD (2007) Non-B DNA conformations, mutagenesis and disease. Trends Biochem Sci 32:271–278
Xie Y, Huang X, Liang Y, Xu L, Pei Y, Cheng Y, Zhang L, Tang W (2015) A new compound heterozygous CFTR mutation in a Chinese family with cystic fibrosis. Clin Respir J. doi:10.1111/crj.12401
Acknowledgements
We are grateful to the patient and her family for their contributions to this work. The research was supported by the National Natural Science Foundation of China (31271345) to Yaping Liu; Beijing Municipal Science and Technology Commission (Z151100003915078) and CAMS Innovation Fund for Medical Sciences (2016-I2M-1-002) to Xue Zhang.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interest.
Ethics approval and consent to participate
The protocol of this study was approved by the Institutional Review Board committee at PUMCH. Signed informed consents were obtained from all individual participants included in the study.
Additional information
Communicated by S. Hohmann.
Rights and permissions
About this article
Cite this article
Liu, K., Liu, Y., Li, X. et al. A novel homozygous complex deletion in CFTR caused cystic fibrosis in a Chinese patient. Mol Genet Genomics 292, 1083–1089 (2017). https://doi.org/10.1007/s00438-017-1334-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00438-017-1334-0